prion
diseas
like
scrapi
sheep
often
call
transmiss
spongiform
encephalopathi
tse
fatal
neurodegen
diseas
varieti
host
speci
includ
human
associ
convers
normal
host
cellular
prion
protein
prpc
abnorm
proteaseresist
isoform
prpsc
prp
genotyp
influenc
suscept
incub
period
clinic
present
allel
highli
associ
classic
scrapi
sheep
control
prevent
spread
scrapi
genet
screen
breed
resist
wide
use
implement
eu
decis
prp
genotyp
howev
neither
marker
definit
diseas
genet
factor
influenc
prion
diseas
despit
effort
reduc
suscept
monitor
cull
rumin
scrapi
still
exist
today
much
research
prion
diseas
evolv
around
prion
protein
infect
dissemin
studi
rel
littl
done
nonprpsc
diseas
process
recent
larg
scale
survey
preval
prpsc
human
appendix
sampl
britain
suggest
higher
preval
infect
formerli
anticip
human
prp
genotyp
find
necessit
focus
variou
mechan
prion
diseas
develop
progress
variabl
incub
time
complex
epidemiolog
differ
variabl
may
influenc
clinic
patholog
pictur
increasingli
import
elucid
differ
omic
studi
tissu
bodi
fluid
like
serum
may
potenti
reveal
marker
contribut
unravel
intric
pathogenesi
prion
diseas
recent
sever
nonprpsc
protein
put
forward
promis
biomark
preclin
scrapi
identif
nonprpsc
biomark
may
crucial
futur
prion
research
surfac
enhanc
laser
desorptionionizationtim
flightmass
spectrometri
selditofm
technolog
ciphergen
biosystem
fremont
ca
usa
design
perform
mass
spectrometri
ms
analysi
protein
mixtur
base
masstocharg
mz
ratio
protein
bind
affin
variou
chip
surfac
singl
charg
protein
molecular
weight
dalton
da
usual
correspond
well
masstocharg
mz
valu
peak
intens
correspond
well
concentr
sampl
differ
protein
express
profil
may
determin
protein
profil
compar
intens
peak
similar
mz
valu
protein
good
indic
current
cellular
function
investig
serum
proteom
repres
one
direct
biomark
research
one
challeng
investig
serum
proteom
complex
presenc
high
abund
blood
protein
particularli
albumin
estim
high
abund
protein
constitut
bulk
mass
protein
repres
less
total
number
protein
high
abund
protein
may
produc
larg
signal
mask
interfer
detect
low
abund
protein
simplifi
sampl
complex
upfront
fraction
procedur
recommend
addit
fraction
achiev
chromatograph
properti
seldi
array
technolog
extract
crucial
inform
retriev
mass
spectrometri
ms
data
challeng
data
often
much
higher
number
variabl
compar
number
sampl
follow
normal
distribut
heteroscedast
variabl
highli
correl
reason
much
effort
invest
find
reliabl
method
assist
interpret
profil
machin
learn
method
repres
one
direct
anoth
latent
variabl
lv
approach
princip
compon
analysi
pca
commonli
use
unsupervis
exploratori
analysi
mass
spectral
data
partial
least
squar
discrimin
analysi
plsda
anoth
method
util
knowledg
group
belong
identifi
discrimin
group
data
problem
plsda
usual
numer
latent
variabl
need
order
achiev
good
discrimin
group
creat
interpret
problem
follow
target
project
tp
method
axi
best
discrimin
group
achiev
interpret
singl
predict
latent
variabl
obtain
rajalahti
et
al
develop
quantit
display
call
select
ratio
sr
plot
select
biomark
spectral
profil
sr
plot
provid
rank
object
measur
probabl
guid
investig
select
process
result
specif
protein
fingerprint
profil
classifi
unknown
sampl
control
infect
group
suggest
possibl
classifi
sampl
base
multipl
biomark
pattern
therefor
constrain
sensit
specif
singl
biomark
work
selditofm
technolog
use
analysi
prefraction
serum
sampl
describ
data
process
step
follow
latent
variabl
project
method
use
visual
variat
highlight
variabl
separ
group
question
time
euthanasia
week
post
inocul
wpi
scrapi
infect
anim
show
typic
sign
scrapi
pruritu
ataxia
reduc
live
weight
weak
coordin
poor
wool
qualiti
none
anim
control
group
show
clinic
sign
scrapi
brain
materi
group
inocul
materi
use
examin
western
blot
wb
presenc
prpsc
result
present
figur
reproduc
selditof
ms
analysi
evalu
basi
calcul
coeffici
variat
cv
peak
intens
mz
pool
cv
cvp
calcul
result
region
report
other
shown
tabl
cvp
mass
accuraci
across
sampl
pca
analysi
perform
ms
data
endstag
studi
es
longitudin
studi
ls
basi
peak
cluster
deriv
biomark
wizard
featur
bw
includ
ciphergen
softwar
score
plot
present
figur
respect
pca
analysi
use
sole
visualis
purpos
score
plot
figur
demonstr
healthi
anim
infect
anim
segreg
well
clinic
endstag
week
pi
poorli
asymptomat
incub
period
princip
compon
one
pc
describ
variat
data
set
much
variat
account
scrapi
unknown
method
take
group
belong
account
data
set
ls
analys
lv
method
due
low
number
peak
select
bw
make
method
suitabl
ls
data
analys
nonparametr
u
test
signific
differ
individu
peak
intens
group
sampl
time
result
peak
mz
valu
signific
level
fold
chang
list
tabl
data
clinic
end
stage
studi
analys
plsda
use
group
classif
depend
variabl
five
compon
shown
possess
predict
inform
accord
cross
valid
model
use
variabl
protein
profil
explanatori
variabl
explain
varianc
group
membership
respons
variabl
indic
excel
predict
model
plsda
model
use
basi
tp
model
result
tp
score
graphic
present
figur
show
excel
discrimin
healthi
control
infect
anim
tp
model
use
variabl
protein
profil
explain
varianc
group
membership
indic
variat
mass
spectral
data
relat
diseas
statu
therefor
remov
tp
model
two
model
summar
tabl
choos
mean
correct
classif
rate
mccr
mean
wilcoxon
rank
sum
sensit
threshold
select
discrimin
peak
discrimin
variabl
diva
plot
indic
correspond
select
ration
sr
threshold
figur
abl
select
ten
variabl
present
select
ratio
plot
figur
individu
wilcoxon
classif
rate
sensit
rang
per
cent
tabl
ten
peak
use
new
pca
analysi
visual
impress
distribut
anim
basi
ten
peak
figur
illustr
pca
score
plot
two
group
well
separ
along
pc
indic
ten
variabl
highli
relat
group
differ
ie
scrapi
versu
healthi
intens
standard
deviat
seldi
peak
repres
mz
valu
plot
bar
diagram
present
figur
see
ten
protein
overexpress
clinic
end
stage
scrapi
serum
amyloid
saa
protein
identifi
eight
peptid
use
high
confid
filter
give
coverag
saa
identifi
scrapi
sampl
peptid
sequenc
saa
identifi
peptid
shown
figur
saa
consist
amino
acid
theoret
molecular
weight
da
correspond
well
one
select
seldi
peak
mz
data
seldi
peak
present
tabl
studi
evalu
use
seldimstof
data
latent
variabl
method
creat
analys
serum
protein
profil
data
discrimin
healthi
sheep
sheep
scrapi
variou
stage
incub
period
clinic
endstag
batxellimolina
et
al
discrimin
sheep
earli
phase
scrapi
healthi
control
use
four
seldi
peak
sensit
specif
respect
abl
creat
good
predict
regress
model
clinic
end
stage
data
base
ten
peak
discrimin
scrapi
affect
anim
control
sensit
one
ten
select
seldi
peak
rel
high
intens
scrapi
group
bare
detect
control
group
peak
mass
mz
da
mean
sensit
base
result
lsmsm
analysi
sampl
control
group
scrapi
group
peak
identifi
serum
amyloid
saa
find
correspond
well
previous
publish
data
quantit
measur
saa
serum
sampl
anim
rang
differ
univari
multivari
data
analysi
method
differ
softwar
use
analys
seldi
spectral
data
believ
multivari
method
base
latent
variabl
better
suit
method
handl
data
variabl
observ
data
noisi
highli
collinear
provid
good
tool
visual
data
detect
pattern
object
classif
latent
variabl
model
reduc
dimension
data
reveal
underli
concept
structur
method
report
other
produc
good
result
selditof
ms
data
howev
due
peak
variabl
dataset
longitudin
studi
abl
creat
predict
model
without
increas
risk
overfit
regress
model
abl
defin
valid
compon
plsda
model
time
achiev
satisfactori
cross
valid
data
result
longitudin
studi
therefor
evalu
visual
pca
method
individu
peak
evalu
signific
mann
whitney
u
test
although
signific
pvalu
observ
sampl
time
result
interpret
care
due
poor
reproduc
selditofm
analysi
risk
fals
posit
due
multipl
comparison
problem
aris
high
number
peak
independ
compar
two
group
pca
power
techniqu
data
visual
unsupervis
method
includ
varianc
data
analysi
use
priori
inform
regard
group
membership
much
varianc
may
also
due
nonscrapi
relat
differ
anim
sex
age
genet
sampl
time
individu
physiolog
factor
import
biomark
pattern
serum
proteom
may
buri
major
differ
use
method
take
group
membership
account
diseas
relev
differ
may
becom
clear
illustr
use
plsda
analys
es
data
model
focus
maximum
separ
two
group
contrast
maximum
variat
pca
model
plsda
model
give
rise
larg
number
pl
compon
requir
describ
major
variat
data
combin
pl
compon
singl
tp
compon
repres
direct
multivari
predict
space
strongest
relat
respons
interpret
becom
easi
inform
correl
group
membership
remov
tp
score
vector
display
discrimin
inform
two
group
singl
scale
illustr
summaris
tabl
show
total
varianc
data
use
describ
predict
model
reduc
tp
model
plsda
model
tp
model
also
provid
quantit
measur
origin
variabl
contribut
discrimin
group
peak
larg
varianc
littl
correl
group
membership
may
domin
peak
littl
varianc
high
correl
group
membership
could
directli
use
select
interest
peak
select
ratio
sr
variabl
tp
compon
directli
relat
variabl
abil
predict
group
membership
use
select
variabl
model
describ
rajalahti
et
al
sensit
level
correct
classif
rate
set
peak
chosen
individu
data
set
done
statist
nonparametr
wilcoxon
rank
sum
test
complet
random
classif
equal
number
sampl
group
give
correct
classif
rate
correct
classif
sampl
cr
set
sensit
threshold
must
balanc
risk
select
fals
biomark
miss
import
one
studi
chose
mean
sensit
levelcorrect
classif
rate
select
variabl
gave
select
ratio
sr
valu
illustr
diva
plot
figur
sr
valu
appli
variabl
select
ratio
plot
figur
ten
seldi
peak
qualifi
select
sr
valu
threshold
twogroup
comparison
like
work
receiv
oper
characterist
roc
curv
could
use
compar
sensit
specif
biomark
candid
differ
cutoff
valu
peak
intens
correct
classif
rate
ident
sensit
binari
classif
give
us
pictur
diva
plot
expand
multivari
space
ten
select
seldi
peak
use
pca
plot
figur
illustr
well
separ
two
group
question
along
pc
figur
illustr
intens
ten
peak
seldi
spectra
increas
express
scrapi
group
compar
control
group
probabl
relat
clinic
statu
anim
one
peak
mz
da
identifi
lcmsm
serum
amyloid
saa
major
acut
phase
protein
app
sheep
quit
common
identifi
acut
phase
protein
discrimin
biomark
group
affect
affect
individu
highli
sensit
reactant
produc
respons
insult
howev
specif
although
differ
insult
may
produc
differ
pattern
acut
phase
respons
apr
mani
report
diagnost
seldi
peak
found
acut
phase
protein
describ
sever
review
saa
primarili
induc
proinflammatori
cytokin
releas
varieti
cell
includ
activ
tissu
macrophag
blood
monocyt
respons
injuri
sheep
natur
scrapi
mice
experiment
scrapi
show
reactiv
astrocytosi
microglia
activ
increas
cytokin
express
brain
time
clinic
sign
neuropatholog
chang
cytokin
cross
blood
initi
system
apr
increas
synthesi
app
hepatocyt
saa
coe
et
al
report
increas
level
serum
amyloid
p
plasma
mice
scrapi
evid
system
inflammatori
respons
scrapi
batxellimolina
et
al
identifi
transthyretin
underexpress
sheep
clinic
scrapi
transthyretin
neg
app
express
lower
level
apr
along
neg
app
although
identif
app
biomark
diseas
consid
signific
believ
identif
protein
regardless
specif
significantli
differ
scrapi
affect
healthi
control
contribut
novel
inform
underli
patholog
process
scrapi
long
incub
period
larg
varieti
clinic
present
well
lack
direct
link
neuropatholog
prpsc
dissemin
clinic
present
creat
need
new
knowledg
underli
process
stage
scrapi
identif
discrimin
protein
contribut
matter
selditofm
may
excel
tool
protein
profil
due
high
throughput
work
shown
mani
technic
limit
result
lack
peak
identif
poor
reproduc
make
techniqu
choic
search
specif
biomark
challeng
limit
associ
selditofm
nice
reflect
poor
reproduc
longitudin
end
point
studi
low
number
peak
detect
time
point
like
week
method
fail
detect
peak
mz
kda
es
ls
even
though
peak
separ
group
well
high
intens
es
studi
even
though
number
peak
found
significantli
overexpress
scrapi
group
compar
control
group
ls
data
find
limit
valu
long
peak
identifi
specif
protein
elucid
specif
patholog
pathway
process
also
uncertain
whether
individu
peak
separ
protein
sever
peak
repres
protein
differ
charg
modif
also
notic
larg
differ
differ
time
point
even
though
sampl
includ
ls
run
randomli
time
could
due
introduct
variabl
handl
preprocess
sampl
especi
initi
fraction
step
differ
number
peak
detect
group
could
due
suspect
variat
qualiti
quantiti
ft
fraction
point
also
van
gorp
et
al
mani
promis
studi
discrimin
seldi
peak
publish
followup
paper
peak
identif
valid
publish
barr
et
al
actual
propos
protein
fingerprint
tse
infect
blood
creat
proteom
profil
abl
detect
sheep
infect
scrapi
incub
period
high
sensit
specif
rigor
test
larg
number
anim
would
necessari
addit
elimin
variabl
sampl
handl
analyt
procedur
addit
scrapi
neurolog
diseas
would
similarli
map
reproduc
valid
discrimin
proteom
profil
would
need
confirm
across
differ
laboratori
anim
group
includ
differ
genotyp
scrapi
strain
age
group
one
major
limit
factor
seldi
proteom
profil
lack
direct
comparison
seldi
peak
base
sole
mz
differ
experiment
setup
anim
model
data
analysi
result
poor
reproduc
number
peak
detect
peak
height
mz
make
result
peak
list
incompar
comparison
seldi
data
differ
sampl
set
differ
run
across
selditofm
instrument
result
consider
variat
number
discrimin
peak
comparison
made
across
differ
studi
may
also
mislead
one
protein
speci
gener
ten
major
peak
mani
minor
satellit
peak
due
chemic
reaction
may
take
place
sampl
prepar
analysi
protein
approxim
mass
show
overlap
peak
spectra
obtain
differ
machin
set
look
differ
result
also
confirm
problem
sampl
set
ls
es
prepar
analys
two
differ
occas
abl
reproduc
exact
result
end
point
data
set
rel
high
cvp
seen
peak
intens
within
run
indic
slight
chang
peak
intens
group
may
indic
actual
differ
group
thu
care
interpret
result
necessari
problem
may
overcom
consider
increas
number
anim
group
result
across
differ
agegroup
compar
natur
chang
protein
profil
relat
age
chang
may
overshadow
differ
due
diseas
statu
work
similar
group
enhanc
differ
relat
scrapi
minim
differ
relat
preanalyt
factor
like
age
sex
product
statu
genotyp
varianc
attribut
preanalyt
factor
also
minim
one
normal
step
peak
select
two
propos
poon
due
risk
introduc
fals
differ
profil
renorm
difficulti
identif
protein
correspond
seldi
peak
mention
earlier
anoth
major
limit
factor
also
mention
batxellimolina
et
al
much
effort
made
identifi
discrimin
protein
especi
significantli
differ
group
conclus
basi
experiment
infect
model
use
includ
rout
infect
prp
genotyp
anim
believ
result
studi
relev
studi
sever
aspect
natur
infect
classic
scrapi
case
choos
peaksprotein
biomark
research
base
sole
pvalu
univari
model
may
howev
result
number
fals
marker
latent
variabl
method
much
suitabl
type
data
method
simpl
use
nonstatist
user
interpret
made
easi
result
visual
well
present
articl
describ
one
approach
anim
model
data
analysi
result
select
signific
protein
peak
creation
predict
model
result
show
possibl
use
data
selditofm
combin
multivari
data
analysi
discrimin
scrapi
affect
sheep
healthi
control
identifi
one
peak
one
discrimin
protein
serum
amyloid
saa
scrapi
affect
anim
end
stage
howev
practic
applic
predict
model
restrict
due
limit
factor
selditof
ms
multipl
detect
differ
group
might
therefor
complet
illustr
omic
method
studi
differ
proteom
profil
healthi
scrapi
infect
sheep
undoubtedli
provid
novel
insight
underli
pathogen
patholog
event
howev
long
discrimin
protein
peak
remain
unidentifi
patholog
clinic
relev
actual
protein
relat
scrapi
remain
unknown
conclus
therefor
need
sensit
specif
bioassay
use
identifi
biomark
obtain
method
util
variou
research
group
across
experi
total
lamb
two
consecut
year
includ
studi
prp
genotyp
homozyg
tabl
lamb
inocul
oral
gram
homogen
pool
brain
materi
either
healthi
sheep
confirm
case
classic
scrapi
immedi
birth
ingest
colostrum
group
control
scrapi
group
accord
inocul
materi
inocul
brain
materi
use
group
test
prpsc
wb
figur
lamb
left
mother
confin
isol
box
similar
condit
feed
regim
lamb
use
born
within
time
period
day
post
mortem
examin
obex
area
brain
anim
sampl
detect
prpsc
wb
figur
anim
experi
approv
norwegian
anim
research
author
serum
sampl
use
work
drawn
everi
two
week
six
week
post
infect
pi
euthanasia
longitudin
studi
ls
serum
sampl
time
euthanasia
use
endstag
studi
es
serum
sampl
allow
clot
room
temperatur
minimum
minut
maximum
minut
process
serum
pipet
aliquot
frozen
minu
degre
within
two
hour
sampl
sampl
subject
handl
procedur
throughout
experi
serum
sampl
fraction
prior
selditof
ms
analysi
use
strong
anion
exchang
fraction
kit
q
spin
column
biorad
contain
q
ceram
hyperd
f
sorbent
applic
column
protein
denatur
addit
urea
chapter
mm
ph
buffer
serum
sampl
follow
addit
urea
chapter
mm
ph
buffer
serum
mixtur
ad
column
incub
time
set
minut
degre
rotat
ensur
complet
mix
serum
mixtur
column
sorbent
sampl
fraction
six
fraction
flow
ft
fraction
captur
directli
sampl
incub
consecut
fraction
captur
ad
wash
buffer
decreas
ph
start
ph
end
ph
captur
last
fraction
captur
wash
organ
buffer
differ
fraction
aliquot
store
soon
captur
analysi
weak
cation
exchang
array
array
biorad
combin
high
stringenc
buffer
mm
hepe
ph
bind
wash
buffer
use
analys
flow
ft
fraction
work
ft
fraction
dilut
bind
buffer
applic
array
individu
ls
es
sampl
appli
randomli
onto
array
three
five
replic
respect
matrix
sinapin
acid
spa
energi
absorb
molecul
eam
appli
selditofm
analysi
array
prepar
handl
accord
manufactur
instruct
array
analys
protein
biolog
system
ii
pbsiic
autoload
biorad
laboratori
use
ciphergen
softwar
version
softwar
integr
biomark
wizardtm
bw
cluster
analys
softwar
chip
analys
spot
protocol
optim
low
mass
area
lm
kda
spectra
collect
use
averag
laser
shot
es
ls
sampl
prepar
analys
separ
bw
featur
softwar
use
peak
cluster
rang
interest
kda
kda
spectral
data
process
reduc
instrument
handl
artefact
minim
variat
within
group
maxim
variat
group
improv
peak
detect
spectra
name
organis
group
accord
age
sampl
group
belong
control
scrapi
data
process
use
softwar
process
involv
four
step
calibr
baselin
subtract
filter
nois
reduct
normal
tic
final
peak
select
perform
bw
data
process
perform
follow
recommend
describ
biorad
collect
peak
data
export
offic
excel
siriu
version
pattern
recognit
system
bergen
norway
data
analys
spectra
evalu
intracassett
intercassett
reproduc
calcul
coeffici
variat
cv
peak
intens
peak
mass
mz
cv
es
data
set
calcul
sampl
base
peak
inform
five
replic
cv
ls
data
set
calcul
peak
inform
qualiti
control
qc
sampl
repeatedli
run
sampl
calibr
equat
creat
use
calibr
featur
softwar
standard
contain
peptid
protein
known
mass
proteinchip
allinon
peptideprotein
standard
biorad
run
parallel
sampl
one
equat
data
set
es
ls
calcul
appli
spectra
respect
studi
shape
baselin
spectrum
examin
baselin
featur
use
subtract
baselin
fit
width
set
two
time
expect
peak
width
nois
rang
set
kda
exclud
matrix
attenu
rang
analysi
end
set
spectrum
size
baselin
nois
reduc
spectra
normal
use
total
ion
count
tic
normal
featur
softwar
normal
spectrum
equal
sum
detect
signal
curv
region
interest
group
base
age
group
belong
normal
separ
result
normal
factor
creat
spectrum
inspect
evalu
spectra
normal
factor
mean
standard
deviat
exclud
analysi
peak
cluster
gener
use
bw
function
softwar
detect
peak
similar
mass
across
spectra
peak
detect
use
follow
set
firstpass
detect
signaltonois
ratio
cluster
complet
use
secondpass
signaltonois
ratio
peak
need
present
least
spectra
give
presenc
least
half
group
mass
differ
allow
peak
cluster
inform
export
excel
analysi
data
test
differ
rel
peak
intens
two
group
use
nonparametr
u
test
includ
bw
siriu
softwar
fold
chang
intens
calcul
mean
peak
intens
controlmean
peak
intens
scrapi
significantli
downregul
peak
viceversa
upregul
peak
test
signific
level
set
p
latent
variabl
project
method
lv
use
analys
selditofm
data
es
ls
data
analys
princip
compon
analysi
pca
visual
evalu
distribut
data
irrespect
group
belong
es
data
analys
use
lv
method
group
membership
variabl
defin
assign
sampl
control
group
member
scrapi
group
partial
least
squar
discrimin
analysi
plsda
target
project
method
tp
use
evalu
data
distribut
accord
group
membership
analys
spectral
variabl
standard
unit
varianc
therebi
prevent
variabl
high
varianc
domin
data
analysi
nonparametr
discrimin
variabl
test
diva
use
connect
select
ratio
sr
valu
discriminatori
abil
variabl
quantifi
probabl
correct
classif
variabl
got
correct
classif
rate
cr
ie
well
variabl
separ
two
group
question
sr
valu
plot
mean
wilcoxon
rank
sum
rate
obtain
diva
plot
cross
valid
use
es
data
optim
lv
model
respect
predict
perform
differ
procedur
cross
valid
develop
es
data
split
four
group
construct
one
pl
model
group
one
group
use
valid
set
other
train
set
number
pl
compon
chosen
one
give
first
minimum
predict
error
one
es
sampl
group
prepar
process
protein
identif
thirteen
ft
fraction
mix
ld
dtt
sampl
mixtur
heat
minut
iaa
mm
ad
mix
let
incub
minut
room
temperatur
dark
load
clearpag
gel
cb
scientif
usa
gel
run
v
minut
electrophoresi
gel
stain
gelcod
blue
safe
stain
pierc
usa
hour
destain
overnight
ultrapur
water
three
protein
band
region
kda
band
gel
excis
subject
tryptic
digest
use
omx
tube
devic
omx
germani
follow
manufactur
protocol
tryptic
peptid
sampl
sent
intern
research
institut
stavang
iri
mekjarvik
norway
protein
identif
done
accord
standard
oper
procedur
protein
identif
perform
lcmsm
analysi
use
ultim
dual
pump
nanoflow
hplc
system
dionex
sunnyval
ca
usa
connect
linear
ion
traporbitrap
mass
spectromet
ltqorbitrap
xl
thermo
fisher
scientif
waltham
usa
sampl
volum
sampl
load
onto
trap
column
acclaim
id
mm
length
dionex
flow
rate
formic
acid
vwr
milliq
water
elga
cleanup
preconcentr
peptid
separ
analyt
column
acclaim
id
cm
length
dionex
mobil
phase
analyt
separ
consist
formic
acid
acetonitrilewat
formic
acid
acetonitrilewat
b
pump
flow
nlmin
peptid
separ
analyt
column
use
linear
gradient
b
min
min
delay
post
inject
gradient
run
b
min
held
min
wash
column
total
run
time
min
use
includ
wash
step
min
reequilibr
column
picotip
emitt
silicatip
new
object
tip
without
coat
use
esi
interfac
electrospray
voltag
set
kv
sheath
ga
use
mass
spectromet
use
posit
mode
full
scan
perform
orbitrap
mz
rang
datadepend
msm
scan
perform
linear
ion
trap
five
abund
mass
z
intens
count
dynam
exclus
use
min
exclus
fragment
given
mz
valu
four
time
collisioninduc
dissoci
cid
use
collis
energi
activ
q
set
activ
time
ms
mass
spectromet
tune
daili
calibr
weekli
use
calibr
solut
recommend
thermo
scientif
ltqorbitrap
raw
file
analys
use
proteom
discover
thermo
fisher
scientif
protein
identif
perform
sequest
algorithm
search
even
to
ungul
databas
avail
ncbi
trypsin
digest
enzym
allow
maximum
two
miss
cleavag
site
carbamidomethyl
c
set
static
modif
oxid
dynam
modif
precursor
ion
fragment
ion
mass
toler
set
ppm
da
respect
result
filter
minimum
peptid
use
high
medium
signific
xcorr
score
adjust
peptid
charg
z
tabl
tse
transmiss
spongiform
encephalopathi
prpc
normal
cellular
prion
protein
prpsc
scrapi
prion
protein
selditofm
surfac
enhanc
laser
desorptionion
timeofflight
mass
spectrometri
pca
princip
compon
analysi
plsda
partial
least
squar
discrimin
analysi
tp
target
project
sr
select
ratio
lcmsm
liquid
chromatographi
tandem
mass
spectrometri
tic
total
ion
current
cv
coeffici
variat
da
dalton
bw
biomark
wizard
pc
princip
compon
mwcr
mean
wilcoxon
classif
rate
diva
discrimin
variabl
z
charg
ld
lithium
dodecyl
sulphat
dtt
dithiothreitol
iaa
iodin
acetamid
lv
latent
variabl
wb
western
blot
wpi
week
post
inocul
author
declar
compet
interest
sm
carri
proteom
studi
statist
data
analysi
particip
protein
identif
draft
manuscript
omk
particip
design
studi
statist
data
analysi
help
draft
manuscript
ra
particip
statist
data
analysi
kb
particip
design
studi
carri
part
protein
identif
help
draft
manuscript
ah
particip
design
perform
proteom
studi
mju
particip
design
coordin
help
draft
manuscript
author
read
approv
final
manuscript
